Rheumnow Podcast

A Step Closer to Identifying Phenotypes of RA ILD

Dr. Mrinalini Dey discusses abstract OP0202 presented at Eular 2024 in Vienna, Austria.

Top 3 Messages About JAK Inhibitor Safety

Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.

Pain in RA: Different Drugs for Different Mechanisms

Dr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.

Giant Cell Arteritis and Polymyalgia Rheumatica Update

Dr. Janet Pope discusses abstracts LBA0001, OP0233, OP0261 and POS0280 at Eular 2024 in Vienna, Austria.

JAK Inhibitors for New Indications

Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.

Top 3 Messages About JAK Inhibitor Safety

Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.

Pain in RA: Different Drugs for Different Mechanisms

Dr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.

JAK Inhibitors for New Indications

Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.

Potential of Radiomics to Predict TNF Therapy Outcomes in axSpA

Dr. Bella Mehta interviews Dr. Vincenzo Venerito about abstract POS0236 at Eular 2024 in Vienna, Austria.

Treat to Target Outcomes in Early AxSpA

Dr. Antoni Chan discusses abstract OP0132 presented at Eular 2024 in Vienna, Austria.